APA (7th ed.) Citation

Dorta Suarez, M., Jimenez Munarriz, B., Del Barrio, A., Garcia Ledo, G., Blanco Blanco, R., Conde Gallego, E., . . . Cubillo Gracián, A. (2021). 12P Molecular features of KRAS mutant NSCLC: Weaving a future score for immune-checkpoint inhibitors (ICI). Annals of Oncology, 32, S1349. https://doi.org/10.1016/j.annonc.2021.08.2008

Chicago Style (17th ed.) Citation

Dorta Suarez, M., B. Jimenez Munarriz, A. Del Barrio, G. Garcia Ledo, R. Blanco Blanco, E. Conde Gallego, S. Hernandez Prieto, F. Lopez Rios, and A. Cubillo Gracián. "12P Molecular Features of KRAS Mutant NSCLC: Weaving a Future Score for Immune-checkpoint Inhibitors (ICI)." Annals of Oncology 32 (2021): S1349. https://doi.org/10.1016/j.annonc.2021.08.2008.

MLA (9th ed.) Citation

Dorta Suarez, M., et al. "12P Molecular Features of KRAS Mutant NSCLC: Weaving a Future Score for Immune-checkpoint Inhibitors (ICI)." Annals of Oncology, vol. 32, 2021, p. S1349, https://doi.org/10.1016/j.annonc.2021.08.2008.